The expansion of Kallir Philips Ross (KPR) into overseas markets began in 1975 when Michel Cambier, the international marketing vice president of Janssen Pharmaceutica, Belgium, assigned the launch of Imodium and Sibelium to the agency. It was a hold decision, because European drug companies didn't hire ad agencies in those days—let alone one that was more than 3000 miles away. Imodium was not yet available in the US. Sibelium, a peripheral vasodilator, never made it through the FDA. At first, Cambier preferred to work with KPR in New York, but after a few years KPR s.a. was established in Brussels with Stef Eyckmans as its managing director. Of course, KPR continued to handle Imodium and many other Janssen products when the company moved into "J&J Land" in New Jersey. A further expansion took place in 1983. After KPR had been acquired by Doyle Dane Bernbach, Paling Ellis in London became part of the KPR network. The European subsidiaries continued to service their local accounts, as well as those of KPR International. The Maturing of the Marketplace Since the 1980s, many more healthcare agencies have formed networks and have gone global. These networks include dedicated healthcare agencies within larger consumer advertising and communications holding companies—including Cline, Davis & Mann (CDM World Agency), DDB Healthcare, DraftFCB Healthcare, Euro RSCG Life, Grey Healthcare Group, Huntsworth Health, InVentiv Health, Lowe Healthcare Worldwide, McCann Healthcare Worldwide, Ogilvy Healthworld, Publicis Healthcare Communications Croup and TBWA/WorldHealth Global—as well as newer global agency networks such as Argon and Indigenus, which have been drawn together from a series of independent agencies around the world.
RkJQdWJsaXNoZXIy NDMwNDAx